Systech Launches UniSecure artAI, an AI-Powered Authentication Solution for the Life Sciences and Pharmaceutical Industries
Systech, a Dover company, has launched UniSecure artAI™, an AI-powered authentication solution for life sciences and pharmaceutical industries. This cloud-based SaaS solution utilizes existing packaging artwork and AI applications including machine vision, machine learning, and neural networks to combat counterfeiting and ensure packaging quality.
The solution addresses the growing challenge of counterfeit medicine trafficking, which generates up to $432 billion annually according to NIH. artAI creates digital blueprints of packaging artwork features for verification and quality inspection through pattern recognition, offering both mobile application scanning and forensic platform capabilities.
Key features include fast deployment with real-time detection, AI-powered forensic intelligence, retroactive and proactive protection, and reduced carbon footprint through centralized operations. The system requires no packaging changes or hardware integration, enabling rapid deployment and immediate value for pharmaceutical brands.
Systech, un'azienda di Dover, ha lanciato UniSecure artAI™, una soluzione di autenticazione basata su intelligenza artificiale per le industrie delle scienze della vita e farmaceutiche. Questa soluzione SaaS basata su cloud utilizza opere d'arte di imballaggio esistenti e applicazioni di intelligenza artificiale, tra cui visione artificiale, apprendimento automatico e reti neurali, per combattere la contraffazione e garantire la qualità dell'imballaggio.
La soluzione affronta la crescente sfida del traffico di medicinali contraffatti, che genera fino a 432 miliardi di dollari all'anno secondo il NIH. artAI crea progetti digitali delle caratteristiche delle opere d'arte di imballaggio per la verifica e l'ispezione della qualità attraverso il riconoscimento dei modelli, offrendo sia capacità di scansione tramite applicazione mobile che piattaforme forensi.
Le caratteristiche principali includono un'implementazione rapida con rilevamento in tempo reale, intelligenza forense alimentata da AI, protezione retroattiva e proattiva, e una riduzione dell'impatto ambientale attraverso operazioni centralizzate. Il sistema non richiede modifiche all'imballaggio o integrazione hardware, consentendo un'implementazione rapida e un valore immediato per i marchi farmaceutici.
Systech, una empresa de Dover, ha lanzado UniSecure artAI™, una solución de autenticación impulsada por inteligencia artificial para las industrias de ciencias de la vida y farmacéuticas. Esta solución SaaS basada en la nube utiliza obras de arte de empaque existentes y aplicaciones de IA, incluyendo visión por computadora, aprendizaje automático y redes neuronales, para combatir la falsificación y asegurar la calidad del empaque.
La solución aborda el creciente desafío del tráfico de medicamentos falsificados, que genera hasta 432 mil millones de dólares anualmente según el NIH. artAI crea planos digitales de las características del arte de empaque para verificación e inspección de calidad a través del reconocimiento de patrones, ofreciendo tanto capacidades de escaneo mediante aplicaciones móviles como plataformas forenses.
Las características clave incluyen una implementación rápida con detección en tiempo real, inteligencia forense impulsada por IA, protección retroactiva y proactiva, y una reducción de la huella de carbono a través de operaciones centralizadas. El sistema no requiere cambios en el empaque ni integración de hardware, lo que permite una implementación rápida y un valor inmediato para las marcas farmacéuticas.
Systech, 도버의 한 회사,가 UniSecure artAI™를 출시했습니다. 이는 생명 과학 및 제약 산업을 위한 AI 기반 인증 솔루션입니다. 이 클라우드 기반 SaaS 솔루션은 기존의 포장 아트워크와 기계 비전, 기계 학습, 신경망을 포함한 AI 응용 프로그램을 활용하여 위조 방지 및 포장 품질 보장을 목표로 합니다.
이 솔루션은 NIH에 따르면 매년 최대 4,320억 달러를 생성하는 위조 의약품 밀매의 증가하는 문제를 해결합니다. artAI는 패턴 인식을 통해 검증 및 품질 검사를 위한 포장 아트워크 기능의 디지털 청사진을 생성하며, 모바일 애플리케이션 스캔 및 포렌식 플랫폼 기능을 제공합니다.
주요 기능으로는 실시간 탐지가 가능한 빠른 배포, AI 기반 포렌식 인텔리전스, 사후 및 사전 보호, 중앙 집중식 운영을 통한 탄소 발자국 감소가 포함됩니다. 이 시스템은 포장 변경이나 하드웨어 통합이 필요 없어 제약 브랜드에 즉각적인 가치를 제공하고 신속한 배포를 가능하게 합니다.
Systech, une entreprise de Dover, a lancé UniSecure artAI™, une solution d'authentification alimentée par l'intelligence artificielle pour les industries des sciences de la vie et pharmaceutiques. Cette solution SaaS basée sur le cloud utilise des œuvres d'art d'emballage existantes et des applications d'IA, y compris la vision par ordinateur, l'apprentissage automatique et les réseaux neuronaux, pour lutter contre la contrefaçon et garantir la qualité de l'emballage.
La solution répond au défi croissant du trafic de médicaments contrefaits, qui génère jusqu'à 432 milliards de dollars par an selon les NIH. artAI crée des plans numériques des caractéristiques des œuvres d'art d'emballage pour la vérification et l'inspection de la qualité grâce à la reconnaissance de motifs, offrant à la fois des capacités de numérisation d'applications mobiles et des plateformes judiciaires.
Les fonctionnalités clés incluent un déploiement rapide avec détection en temps réel, une intelligence judiciaire alimentée par l'IA, une protection rétroactive et proactive, et une réduction de l'empreinte carbone grâce à des opérations centralisées. Le système ne nécessite aucun changement d'emballage ni intégration matérielle, permettant un déploiement rapide et une valeur immédiate pour les marques pharmaceutiques.
Systech, ein Unternehmen aus Dover, hat UniSecure artAI™ eingeführt, eine KI-gestützte Authentifizierungslösung für die Lebenswissenschaften und die Pharmaindustrie. Diese cloudbasierte SaaS-Lösung nutzt bestehende Verpackungsdesigns und KI-Anwendungen, einschließlich maschineller Vision, maschinellem Lernen und neuronalen Netzen, um Fälschungen zu bekämpfen und die Verpackungsqualität sicherzustellen.
Die Lösung begegnet der wachsenden Herausforderung des Handels mit gefälschten Arzneimitteln, der laut NIH jährlich bis zu 432 Milliarden Dollar generiert. artAI erstellt digitale Blaupausen der Merkmale von Verpackungsdesigns zur Überprüfung und Qualitätsinspektion durch Mustererkennung und bietet sowohl mobile Anwendungs-Scanfunktionen als auch forensische Plattformfähigkeiten.
Zu den Hauptmerkmalen gehören eine schnelle Implementierung mit Echtzeiterkennung, KI-gestützte forensische Intelligenz, rückblickender und proaktiver Schutz sowie eine reduzierte CO2-Bilanz durch zentralisierte Abläufe. Das System erfordert keine Änderungen an der Verpackung oder Hardware-Integration, was eine schnelle Implementierung und sofortigen Nutzen für Pharma-Marken ermöglicht.
- Cloud-based SaaS solution requires no hardware integration or packaging changes
- Addresses $432B counterfeit medicine market opportunity
- Dual functionality: counterfeit detection and quality control
- Cost-efficient: reduces resources needed for quality inspection and forensic analysis
- None.
Insights
Dover 's subsidiary Systech has launched UniSecure artAI, an AI-powered authentication solution targeting the $432 billion counterfeit medicine market. This strategic move extends Dover's digital capabilities in the high-margin pharmaceutical sector through a SaaS offering that requires no hardware modifications or packaging changes.
The solution addresses two critical market needs simultaneously: counterfeit prevention and quality control. By leveraging machine vision and AI to create digital fingerprints from existing packaging, Systech offers pharmaceutical manufacturers a frictionless implementation path with potentially rapid ROI through reduced counterfeit losses and quality control improvements.
This launch aligns with Dover's strategic focus on expanding high-margin digital offerings within its Imaging & Identification segment, which contributed approximately
The timing is particularly strategic as pharmaceutical manufacturers face intensifying regulatory pressure worldwide to implement more sophisticated track-and-trace systems. By offering both retroactive protection for products already in market and proactive quality inspection capabilities, Systech addresses compliance needs while providing operational efficiencies through digitized processes and reduced carbon footprint.
For Dover investors, this represents incremental growth potential in a high-margin software segment with recurring revenue characteristics, complementing their traditionally hardware-focused portfolio while expanding their addressable market in pharmaceutical manufacturing technology.
"We are thrilled to introduce artAI, a ground-breaking offering that underscores our commitment to providing cutting-edge solutions to challenges ranging from counterfeiting and diversion to upholding the highest level of quality," said Sreedhar Patnala, General Manager, Systech. "artAI enables brands to quickly identify and resolve issues and roll out packaging quality checks and counterfeit protection at scale. It is easy to use, does not require packaging changes, can be deployed rapidly and provides immediate value."
Counterfeit medicine trafficking is one of the world's fastest-growing criminal enterprises, with the illicit, fraudulent or substandard drug market generating up to an estimated
artAI uses advanced machine vision and machine learning to create a digital blueprint of key packaging artwork features, enabling precise verification and quality inspection through pattern recognition. The solution includes an easy-to-use mobile application for simple product scanning and a robust forensic platform to quickly get to the root of the problem. With advanced analytics and reporting, artAI significantly reduces the resources required to identify and resolve critical issues.
Key benefits:
- Fast deployment & real-time detection: Uses existing packaging to inspect products immediately; no hardware integration required.
- Unparalleled forensic intelligence: AI-powered forensic tools and reporting provide extensive data to investigate packaging issues and supply chain threats while providing actionable, robust analytics.
- Retroactive & proactive protection: Products already in the marketplace are automatically protected under the brand protection program, while production inline applications for quality inspection provide coverage before products are shipped.
- Carbon footprint reduction: A centralized platform removes the need to ship physical samples or deploy additional forensic resources.
With artAI, brand protection and quality assurance teams can digitize processes, significantly reduce resources and enable rapid return on their investment while keeping patients safe. For more information about artAI, please visit systechone.com.
About Systech:
Systech provides digital identification and traceability solutions that establish essential product data, ensure digital connectivity, and enable real-time insights on the packaging line and throughout the supply chain. With decades of experience in pharmaceutical packaging execution and serialization, Systech offers comprehensive, easily configured, turnkey software solutions with reliable implementation and expert support. Global brands across industries rely on Systech's platform to help them achieve their objectives in compliance, resiliency, sustainability, and digital transformation. Systech is a leading brand of Markem-Imaje®, a global product identification, packaging intelligence, and connected product solutions provider and a part of Dover Corporation. Visit www.systechone.com for further information.
About Markem-Imaje:
Markem-Imaje, a wholly owned subsidiary of the US-based Dover Corporation is a trusted world manufacturer of product identification and traceability solutions, offering a full line of reliable and innovative inkjet, thermal transfer, laser, and print and apply label systems. Markem-Imaje provides global reach to over 50,000 customers with 30 subsidiaries, 6 technology centers, several equipment repair centers and manufacturing plants with the most comprehensive marking and coding portfolio available in the marketplace. Visit www.markem-imaje.com for further information.
About Dover:
Dover is a diversified global manufacturer and solutions provider with annual revenue of over
Systech Contact:
Jim Waters
(609) 395-8400
pr@systechone.com
Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com
Dover Investor Contact:
Jack Dickens, VP, Investor Relations
(630) 743-2566
jdickens@dovercorp.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/systech-launches-unisecure-artai-an-ai-powered-authentication-solution-for-the-life-sciences-and-pharmaceutical-industries-302386272.html
SOURCE Dover
FAQ
What is the estimated market size of counterfeit medicines that Systech's artAI aims to combat?
How does Systech's new artAI solution protect pharmaceutical products?
What are the key operational benefits of Systech's artAI for pharmaceutical companies?
Does Systech's artAI require changes to existing product packaging?
